CX Institutional’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Sell
1,221
-1,862
-60% -$30.7K ﹤0.01% 1178
2026
Q1
$50K Sell
3,083
-1,406
-31% -$22K ﹤0.01% 974
2025
Q4
$67K Sell
4,489
-3,186
-42% -$45K ﹤0.01% 923
2025
Q3
$99K Sell
7,675
-87,668
-92% -$1.17M ﹤0.01% 822
2025
Q2
$1.45M Buy
95,343
+47,515
+99% +$741K 0.05% 223
2025
Q1
$799K Buy
47,828
+9,924
+26% +$183K 0.03% 304
2024
Q4
$714K Sell
37,904
-26,724
-41% -$515K 0.03% 296
2024
Q3
$1.21M Sell
64,628
-225,649
-78% -$4.32M 0.05% 259
2024
Q2
$5.48M Sell
290,277
-23,149
-7% -$395K 0.26% 97
2024
Q1
$5.09M Buy
+313,426
New +$4.59M 0.25% 97
2019
Q3
Sell
-82
Closed -$1K 929
2019
Q2
$1K Buy
+82
New +$648 ﹤0.01% 900

Other funds holding SEM

CX Institutional's SEM Position: Q2 2026 in Review

CX Institutional reduced its Select Medical (SEM) stake by 60% in Q2 2026, selling an estimated $30.7K and leaving 1,221 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

CX Institutional first reported a position in SEM in Q2 2019 and has held it in 11 quarters since. The position peaked at $5.48M in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • CX Institutional held 1,221 shares of Select Medical worth $20K as of Q2 2026.
  • CX Institutional sold 1,862 Select Medical shares in Q2 2026, an estimated $30.7K.
  • Select Medical made up ﹤0.01% of CX Institutional's portfolio in Q2 2026, its #1178 holding.
  • CX Institutional first reported a position in Select Medical in Q2 2019 and has held it in 11 quarters since.
  • CX Institutional's Select Medical position peaked at $5.48M in Q2 2024.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.